30/10/2024
|
07:00
|
Update on proposed sub-license of VAL201
|
RNS
|
18/10/2024
|
07:00
|
Directorate Change
|
RNS
|
14/10/2024
|
07:00
|
Investor Webinar
|
RNS
|
07/10/2024
|
07:00
|
Inaphaea Co-Marketing Agreement
|
RNS
|
27/09/2024
|
07:00
|
Half-year Report
|
RNS
|
26/09/2024
|
07:00
|
Conclusion of Evaluation Project
|
RNS
|
24/09/2024
|
07:00
|
Inaphaea Co-Marketing Agreement
|
RNS
|
18/09/2024
|
07:00
|
Inaphaea Evaluation and Commercial Use Agreement
|
RNS
|
16/09/2024
|
07:00
|
Inaphaea Co-Marketing Agreement
|
RNS
|
09/09/2024
|
07:00
|
Inaphaea Evaluation and Commercial Use Agreement
|
RNS
|
09/09/2024
|
07:00
|
Investor Evening
|
RNS
|
27/08/2024
|
07:00
|
Inaphaea Evaluation and Commercial Use Agreement
|
RNS
|
12/08/2024
|
07:00
|
Directorate Change
|
RNS
|
25/07/2024
|
07:00
|
Directorate Changes
|
RNS
|
03/07/2024
|
08:51
|
Proposed Director Appointment
|
RNS
|
20/06/2024
|
17:56
|
Result of AGM
|
RNS
|
19/06/2024
|
11:33
|
Directorate Change
|
RNS
|
17/06/2024
|
07:00
|
Inaphaea Contract Award
|
RNS
|
28/05/2024
|
07:00
|
Investor Webinar
|
RNS
|
20/05/2024
|
12:00
|
Business Update
|
RNS
|
16/05/2024
|
07:00
|
Further re Final Results
|
RNS
|
15/05/2024
|
07:00
|
Final Results and Notice of AGM
|
RNS
|
22/04/2024
|
07:00
|
Directorate Changes
|
RNS
|
21/03/2024
|
07:00
|
Evaluation Agreement with Imperial College London
|
RNS
|
19/03/2024
|
07:00
|
Board Re-structuring and update on requisition
|
RNS
|
04/03/2024
|
17:47
|
Shareholder Requisition Notice
|
RNS
|
04/03/2024
|
07:00
|
Proposed Appointment of Non-Executive Director
|
RNS
|
29/02/2024
|
14:00
|
Proposed Appointment of Non-Executive Director
|
RNS
|
13/02/2024
|
14:20
|
Further re Shareholder Requisition Notice
|
RNS
|
09/02/2024
|
17:06
|
Shareholder Requisition Notice
|
RNS
|
19/01/2024
|
07:00
|
Change of Broker
|
RNS
|
18/01/2024
|
07:00
|
Directorate Change
|
RNS
|
04/01/2024
|
13:48
|
Result of GM, Issue of Equity
|
RNS
|
19/12/2023
|
18:11
|
Result of Retail Offer, Subscription
|
RNS
|
15/12/2023
|
07:00
|
Posting of Circular, Notice of GM and Ops Review
|
RNS
|
13/12/2023
|
16:56
|
Retail Offer
|
RNS
|
13/12/2023
|
16:49
|
Conditional Fundraise, Notice of General Meeting
|
RNS
|
05/12/2023
|
07:00
|
Agreement to License VAL401 to Ambrose Healthcare
|
RNS
|
10/11/2023
|
07:00
|
Evaluation Agreement with StingRay Bio
|
RNS
|
06/10/2023
|
10:45
|
Statement re Share Price Movement
|
RNS
|
28/09/2023
|
07:00
|
Operational Review
|
RNS
|
24/08/2023
|
07:00
|
Half-year Report
|
RNS
|
14/08/2023
|
07:00
|
Collaborative Services Agreement
|
RNS
|
28/06/2023
|
14:15
|
Result of AGM
|
RNS
|
16/06/2023
|
07:00
|
Conclusion of Hokkaido Evaluation Agreement
|
RNS
|
14/06/2023
|
07:00
|
Asset Purchase – Imagen Therapeutics
|
RNS
|
08/06/2023
|
07:00
|
Update on proposed sub-license of VAL201
|
RNS
|
07/06/2023
|
07:00
|
Expanded agreement with University of Barcelona
|
RNS
|
05/06/2023
|
07:00
|
Final Results and Notice of AGM
|
RNS
|
26/05/2023
|
07:00
|
Notice of Results and Investor Webinar
|
RNS
|